Aim Immunotech Inc.
Clinical trials sponsored by Aim Immunotech Inc., explained in plain language.
-
Experimental drug tested for debilitating fatigue condition
Disease control TEMPORARILY_NOT_AVAILABLEThis study is testing an experimental drug called Ampligen in adults with severely debilitating chronic fatigue syndrome (CFS). Participants receive the drug through regular infusions but are responsible for paying all treatment-related costs themselves. The goal is to see if Amp…
Sponsor: AIM ImmunoTech Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo trial aims to hold back deadly pancreatic cancer
Disease control TerminatedThis study is testing if adding an investigational drug called Ampligen to standard cancer care helps people with locally advanced pancreatic cancer live longer without their cancer getting worse. It will compare the combination to standard care alone in about 90 people who have …
Phase: PHASE2 • Sponsor: AIM ImmunoTech Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC